These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 10947948)

  • 1. Comparison of the kinetic properties of the lipid- and protein-kinase activities of the p110alpha and p110beta catalytic subunits of class-Ia phosphoinositide 3-kinases.
    Beeton CA; Chance EM; Foukas LC; Shepherd PR
    Biochem J; 2000 Sep; 350 Pt 2(Pt 2):353-9. PubMed ID: 10947948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Both p110alpha and p110beta isoforms of phosphatidylinositol 3-OH-kinase are required for insulin signalling in the hypothalamus.
    Tups A; Anderson GM; Rizwan M; Augustine RA; Chaussade C; Shepherd PR; Grattan DR
    J Neuroendocrinol; 2010 Jun; 22(6):534-42. PubMed ID: 20236230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cloning, expression, purification, and characterization of the human Class Ia phosphoinositide 3-kinase isoforms.
    Meier TI; Cook JA; Thomas JE; Radding JA; Horn C; Lingaraj T; Smith MC
    Protein Expr Purif; 2004 Jun; 35(2):218-24. PubMed ID: 15135396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of oncogenic p110alpha subunit mutations on the lipid kinase activity of phosphoinositide 3-kinase.
    Carson JD; Van Aller G; Lehr R; Sinnamon RH; Kirkpatrick RB; Auger KR; Dhanak D; Copeland RA; Gontarek RR; Tummino PJ; Luo L
    Biochem J; 2008 Jan; 409(2):519-24. PubMed ID: 17877460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of PI 3-kinase p110beta in AKT signally, cell survival, and proliferation in human prostate cancer cells.
    Hill KM; Kalifa S; Das JR; Bhatti T; Gay M; Williams D; Taliferro-Smith L; De Marzo AM
    Prostate; 2010 May; 70(7):755-64. PubMed ID: 20058239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A specific function for phosphatidylinositol 3-kinase alpha (p85alpha-p110alpha) in cell survival and for phosphatidylinositol 3-kinase beta (p85alpha-p110beta) in de novo DNA synthesis of human colon carcinoma cells.
    Bénistant C; Chapuis H; Roche S
    Oncogene; 2000 Oct; 19(44):5083-90. PubMed ID: 11042696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. eIF4E binding protein 1 and H-Ras are novel substrates for the protein kinase activity of class-I phosphoinositide 3-kinase.
    Foukas LC; Shepherd PR
    Biochem Biophys Res Commun; 2004 Jun; 319(2):541-9. PubMed ID: 15178440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tyrosine phosphorylation is involved in phosphatidylinositol 3-kinase activation in bovine rod outer segments.
    Guo XX; Huang Z; Bell MW; Chen H; Anderson RE
    Mol Vis; 2000 Nov; 6():216-21. PubMed ID: 11063755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of PI3K class IA isoforms with regulatory subunit p55alpha using a scintillation proximity assay.
    Van Aller GS; Carson JD; Fernandes C; Lehr R; Sinnamon RH; Kirkpatrick RB; Tummino PJ; Luo L
    Anal Biochem; 2008 Dec; 383(2):311-5. PubMed ID: 18814837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific role of phosphoinositide 3-kinase p110alpha in the regulation of phagocytosis and pinocytosis in macrophages.
    Tamura N; Hazeki K; Okazaki N; Kametani Y; Murakami H; Takaba Y; Ishikawa Y; Nigorikawa K; Hazeki O
    Biochem J; 2009 Sep; 423(1):99-108. PubMed ID: 19604150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of class I phosphoinositide 3-kinase activity impairs proliferation and triggers apoptosis in acute promyelocytic leukemia without affecting atra-induced differentiation.
    Billottet C; Banerjee L; Vanhaesebroeck B; Khwaja A
    Cancer Res; 2009 Feb; 69(3):1027-36. PubMed ID: 19176369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The SH3 and BH domains of the p85alpha adapter subunit play a critical role in regulating class Ia phosphoinositide 3-kinase function.
    Beeton CA; Das P; Waterfield MD; Shepherd PR
    Mol Cell Biol Res Commun; 1999 May; 1(2):153-7. PubMed ID: 10356365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Class II phosphoinositide 3-kinase is activated by insulin but not by contraction in skeletal muscle.
    Soos MA; Jensen J; Brown RA; O'Rahilly S; Shepherd PR; Whitehead JP
    Arch Biochem Biophys; 2001 Dec; 396(2):244-8. PubMed ID: 11747303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations in the catalytic subunit of class IA PI3K confer leukemogenic potential to hematopoietic cells.
    Horn S; Bergholz U; Jücker M; McCubrey JA; Trümper L; Stocking C; Bäsecke J
    Oncogene; 2008 Jul; 27(29):4096-106. PubMed ID: 18317450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigating the role of class-IA PI 3-kinase isoforms in adipocyte differentiation.
    Kim JE; Shepherd PR; Chaussade C
    Biochem Biophys Res Commun; 2009 Feb; 379(4):830-4. PubMed ID: 19114029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxidants depress the synthesis of phosphatidylinositol 4,5-bisphosphate in heart sarcolemma.
    Mesaeli N; Tappia PS; Suzuki S; Dhalla NS; Panagia V
    Arch Biochem Biophys; 2000 Oct; 382(1):48-56. PubMed ID: 11051096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential regulation of class IA phosphoinositide 3-kinase catalytic subunits p110 alpha and beta by protease-activated receptor 2 and beta-arrestins.
    Wang P; Kumar P; Wang C; Defea KA
    Biochem J; 2007 Dec; 408(2):221-30. PubMed ID: 17680774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. P110delta, a novel phosphoinositide 3-kinase in leukocytes.
    Vanhaesebroeck B; Welham MJ; Kotani K; Stein R; Warne PH; Zvelebil MJ; Higashi K; Volinia S; Downward J; Waterfield MD
    Proc Natl Acad Sci U S A; 1997 Apr; 94(9):4330-5. PubMed ID: 9113989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and purification of PI3 kinase alpha and development of an ATP depletion and an alphascreen PI3 kinase activity assay.
    Boldyreff B; Rasmussen TL; Jensen HH; Cloutier A; Beaudet L; Roby P; Issinger OG
    J Biomol Screen; 2008 Dec; 13(10):1035-40. PubMed ID: 19036708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting the PI3K p110alpha isoform inhibits medulloblastoma proliferation, chemoresistance, and migration.
    Guerreiro AS; Fattet S; Fischer B; Shalaby T; Jackson SP; Schoenwaelder SM; Grotzer MA; Delattre O; Arcaro A
    Clin Cancer Res; 2008 Nov; 14(21):6761-9. PubMed ID: 18980969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.